FAILED
首站-论文投稿智能助手
典型文献
Pre-treatment Drug Resistance Could Impact the 96-Week Antiretroviral Efficacy in Treatment-Naive HIV-1-Infected Patients in Guangdong, China
文献摘要:
Background::With the high prevalence of pre-treatment drug resistance (PDR) and the potential impact to the virological inhibition, the detection of PDR was particularly necessary. This study aimed to determine the prevalence of PDR in Guangdong, China, and its impact on antiretroviral therapy (ART) in treatment-naive HIV patients.Methods::A retrospective cohort study was conducted. A total of 1936 HIV-1-infected treatment-naive patients in the clinic of the infectious department, Guangzhou Eighth People’s Hospital, between August 2018 and December 2019 were assayed for PDR mutations before initiating ART. Patients with PDR mutations (PDR arm) were screened and compared with those without drug-resistant mutations (non-PDR arm). The rate of HIV-1 virologic failure (VF) and CD4 + T-cell counts of the 2 arms were compared at the 96th week after ART to evaluate the impact of PDR on the efficacy of ART. Results::Pretreatment drug resistance was detected in 125 cases (6.46%) from the 1936 enrolled participants, most of which were resistant to non-nucleoside reverse transcriptase inhibitors (64.00%, 80/125). One hundred and eight of 125 completed the follow-up of 96 weeks (PDR arm). In this cohort, 52 patients whose ART regimen containing the resistant drug were grouped as con-PDR arm, and the remaining 56 patients whose ART regimen did not contain the resistant drug were grouped as non-con-PDR arm. A total of 125 patients without PDR were randomly selected as the control group (non-PDR arm), 112 of whom had completed the 96-week follow-up. At the 96th week after ART initiation, 7 patients (6.5%, 7/108) in the PDR arm and 1 patient (0.9%, 1/112) in the non-PDR arm developed VF, exhibiting a significant difference ( χ2 = 4.901, P = 0.029). Meanwhile, 3 patients (5.8%, 3/52) in the con-PDR arm developed VF; the rate was also higher than that in the non-PDR arm, but without a significant difference ( χ2 = 3.549, P = 0.095). The CD4 + T-cell count in the non-PDR arm increased more than the PDR arm (386.6 vs. 319.1 cells/μL, t = 2.448, P = 0.015) or the con-PDR arm (386.6 vs. 325.1 cells/μL, t = 1.821, P = 0.070) at 12 weeks after ART. However, no significant differences were observed in the CD4 + T-cell count from the 24th week after ART onward. Conclusions::Pretreatment drug resistance was moderately prevalent in Guangdong, China, and could affect the antiretroviral efficacy during a 96-week observation period, indicating the need to closely monitor PDR before ART initiation.
文献关键词:
Prevalence;Pretreatment drug resistance;Antiretroviral therapy;Virologic failure
作者姓名:
Guo Pengle;Lan Yun;Li Quanmin;Ling Xuemei;Li Junbin;Tang Xiaoping;Hu Fengyu;Cai Weiping;Li Linghua
作者机构:
Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province 510060, China
引用格式:
[1]Guo Pengle;Lan Yun;Li Quanmin;Ling Xuemei;Li Junbin;Tang Xiaoping;Hu Fengyu;Cai Weiping;Li Linghua-.Pre-treatment Drug Resistance Could Impact the 96-Week Antiretroviral Efficacy in Treatment-Naive HIV-1-Infected Patients in Guangdong, China)[J].感染性疾病和免疫(英文),2022(04):233-238
A类:
96th,Virologic
B类:
Drug,Resistance,Could,Impact,Week,Antiretroviral,Efficacy,Treatment,Naive,HIV,Infected,Patients,Guangdong,China,Background,With,prevalence,drug,resistance,PDR,potential,impact,virological,inhibition,detection,was,particularly,necessary,This,study,aimed,determine,its,antiretroviral,therapy,ART,naive,patients,Methods,retrospective,cohort,conducted,total,infected,clinic,infectious,department,Guangzhou,Eighth,People,Hospital,between,August,December,were,assayed,mutations,before,initiating,screened,compared,those,without,resistant,failure,VF,CD4 ,counts,arms,after,evaluate,efficacy,Results,Pretreatment,detected,cases,from,enrolled,participants,most,which,nucleoside,reverse,transcriptase,inhibitors,One,hundred,eight,completed,follow,weeks,this,whose,regimen,containing,grouped,remaining,did,not,randomly,selected,control,whom,had,At,initiation,developed,exhibiting,significant,Meanwhile,also,higher,than,that,but,increased,more,cells,However,differences,observed,24th,onward,Conclusions,moderately,prevalent,could,affect,during,observation,period,indicating,need,closely,monitor,Prevalence
AB值:
0.417831
相似文献
Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study
Jia Jingya;Zhu Qiuying;Deng Luojia;Lan Guanghua;Johnson Andrew;Chen Huanhuan;Shen Zhiyong;Li Jianjun;Xing Hui;Ruan Yuhua;Li Jing;Lu Hui;Vermund Sten H.;Zhu Jinhui;Qian Han-Zhu-SJTU-Yale Joint Center for Biostatistics and Data Science, Shanghai Jiao Tong University, Shanghai, China;Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China;Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, China;Groton School, Groton, MA, USA;State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China;School of Public Health, Yale University, New Haven, CT, USA
Intensive phototherapy vs. exchange transfusion for the treatment of neonatal hyperbilirubinemia: a multicenter retrospective cohort study
Zhang Meng;He Yang;Tang Jun;Dong Wenbin;Zhang Yong;Zhang Benjin;Wan Hong;Deng Quanmin;Guan Lirong;Xia Bin;Chen Zhong;Ge Min;Zhao Jing;Li Wenxing;Pei Jingjun;Qu Yi;Mu Dezhi-Department of Pediatrics, West China Second Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan 610041, China;Department of Pediatrics, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646099, China;Department of Pediatrics, Sichuan Maternal and Child Health Hospital, Chengdu, Sichuan 610045, China;Department of Pediatrics, Dazhou Central Hospital, Dazhou, Sichuan 635000, China;Department of Pediatrics, Leshan Maternal and Child Health Hospital, Leshan, Sichuan 614000, China;Department of Pediatrics, People’s Hospital of Deyang, Deyang, Sichuan 618000, China;Department of Pediatrics, Mianyang Central Hospital, Mianyang, Sichuan 621000, China
Low rate of pre-exposure prophylaxis and post-exposure prophylaxis uptake and high prevalence of transmitted drug resistance among newly diagnosed primary HIV infections in Shenzhen, China: a real-world retrospective study
Peng Qiaoli;Liu Xiaoning;Tang Xian;Zhang Qiuyue;Zhao Jin;Zheng Chenli;Zhao Fang;Zhou Yang;Zhang Lukun;Sun Liqin;Zhang Haitao;Jia Xinyun;Song Ying;Cao Tingzhi;Wang Siyuan;Rao Man;Chen Zhiwei;Wang Hui;He Yun-National Clinical Research Center for Infectious Diseases, HKU AIDS Institute Shenzhen Research Laboratory, The Third People’s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong 518112, China;National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom;Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong 518073, China;Department of Microbiology, AIDS Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 999077, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。